Xilio Therapeutics, Inc.XLONASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-sales ratio

Latest
17.11
↑ 376% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
3.60
Historical baseline
PeriodValueYoY Change
202517.11+112.4%
20248.06-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-